Consolidated Statement of Operations and Comprehensive Loss - USD ($)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Operating expenses:
Research and development	$ 23,115,123	$ 13,966,368
General and administrative	7,834,155	4,639,928
Change in fair value of convertible affiliated note		9,752,295
Operating loss	(30,949,278)	(28,358,591)
Other income (expense), net:
Interest Income (Expense), Net	253,323	(2,431,614)
Gain on extinguishment of debt		355,515
Other income, net	2,704,743	221,920
Net loss	$ (27,991,212)	$ (30,212,770)
Per common share data:
Basic net loss per common share	$ (0.83)	$ (1.16)
Diluted net loss per common share	$ (0.83)	$ (1.16)
Weighted average number of common shares outstanding, basic	33,672,927	26,025,489
Weighted average number of common shares outstanding, diluted	33,672,927	26,025,489
Other comprehensive gain (loss)
Foreign currency translation gain	$ 332,801	$ 897,769
Comprehensive loss	$ (27,658,411)	$ (29,315,001)